Quick Answer
AVANOS MEDICAL, INC. reported Net Income Loss of -$72.90 million for the year ending 2025.
- AVANOS MEDICAL, INC. showed an increase of +81.4% in Net Income Loss from 2024 to 2025.
- This data is from AVANOS MEDICAL, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 14 years of available data (2012 to 2025), AVANOS MEDICAL, INC.'s Net Income Loss has declined by 147.8%.
- Historical annual values: Fiscal year 2025: -$72.90 million | Fiscal year 2024: -$392.10 million | Fiscal year 2023: -$61.80 million | Fiscal year 2022: $50.50 million | Fiscal year 2021: $6.30 million | Fiscal year 2020: -$29.00 million | Fiscal year 2019: -$45.90 million | Fiscal year 2018: $57.50 million | Fiscal year 2017: $79.30 million | Fiscal year 2016: $39.80 million | Fiscal year 2015: -$426.30 million | Fiscal year 2014: $27.10 million | Fiscal year 2013: $154.60 million | Fiscal year 2012: $152.60 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: